Boothbay Fund Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-70,571
Closed -$752K 1663
2020
Q4
$752K Buy
+70,571
New +$752K 0.03% 493